Alyeska Investment Group, L.P. - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 159 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Alyeska Investment Group, L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2014$1,889,000
-8.5%
145,728
+15.3%
0.04%
-15.2%
Q2 2014$2,064,000
+133.5%
126,440
+152.9%
0.05%
+91.7%
Q1 2014$884,000
-65.0%
50,000
-52.0%
0.02%
-76.0%
Q4 2013$2,523,000–104,200–0.10%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2014
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders